Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Critical Reagent Processing (FRA:DV4) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Critical Reagent Processing's EV-to-EBIT for today is
Critical Reagent Processing's current Enterprise Value is €0.20 Mil.
Critical Reagent Processing's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.32 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Critical Reagent Processing's EV-to-EBITDA for today is:
Critical Reagent Processing's current Enterprise Value is €0.20 Mil.
Critical Reagent Processing's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.32 Mil.
Critical Reagent Processing's current Enterprise Value is €0.20 Mil.
Critical Reagent Processing's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.
Critical Reagent Processing's current Enterprise Value is €0.20 Mil.
Critical Reagent Processing's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.62 Mil.
Critical Reagent Processing's current Enterprise Value is €0.20 Mil.
Critical Reagent Processing's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Critical Reagent Processing Enterprise Value Related Terms
Critical Reagent Processing Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Critical Reagent Processing Enterprise Value Chart
For the Gold subindustry, Critical Reagent Processing's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Critical Reagent Processing Enterprise Value vs Metals & Mining Industry
For the Metals & Mining industry and Basic Materials sector, Critical Reagent Processing's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Critical Reagent Processing's Enterprise Value falls into.
Critical Reagent Processing Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Critical Reagent Processing (FRA:DV4) has a Enterprise Value of €0.20 Mil as of Jul. 21, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Critical Reagent Processing and its competitors.
Is Critical Reagent Processing's Enterprise Value too high?
Critical Reagent Processing's current Enterprise Value is €0.20 Mil. Overall, Critical Reagent Processing has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Critical Reagent Processing's Enterprise Value compare to NEM and AU?
Critical Reagent Processing's Enterprise Value of €0.20 Mil can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Metals & Mining company?
A good Enterprise Value depends on the Metals & Mining industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Critical Reagent Processing and its competitors. Critical Reagent Processing's current Enterprise Value is €0.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Critical Reagent Processing stock overvalued right now?
Critical Reagent Processing (FRA:DV4) has a current Enterprise Value of €0.20 Mil. The current Enterprise Value is €0.20 Mil. Critical Reagent Processing's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Critical Reagent Processing (FRA:DV4), the current Enterprise Value is €0.20 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Critical Reagent Processing Corp is engaged in the acquisition and exploration of mineral properties in Canada. The company explores gold and sodium carbonate. The projects of the company include Laguna Santa Maria Project. The project is comprised of two mining concessions which total 500 hectares. It earns maximum revenue from Argentina.
32GF Score
Get the complete analysis for FRA:DV4
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DV4 has been successfully added to your 
